Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04425434

Therapeutic Recommendations For The Treatment Of Children With A Retinoblastoma

Status
Recruiting
Phase
Study type
Observational
Enrollment
3,000 (estimated)
Sponsor
French Africa Pediatric Oncology Group · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

As the survival of children with retinoblastoma in high income countries is higher than 95% including the bilateral forms this study hopes to improve the outcome in low income countries in Africa by improving early diagnosis and early implementation of this protocol of therapeutic recommendations for treatment.

Detailed description

In this study we will try to improve the outcome for children with stage II disease. It is hoped that we will be able to show that with early intervention correct early diagnosis the survival of these children is greatly improved. The collection of data in this observational study will allow us to show this improvement, by analysis of stage, treatment and outcome.

Conditions

Interventions

TypeNameDescription
OTHEROBSERVATIONALWe will look at the outcome of the the children treated to see if the survival is improved when these therapeutic measures are followed.

Timeline

Start date
2020-11-01
Primary completion
2028-12-31
Completion
2030-12-31
First posted
2020-06-11
Last updated
2026-03-02

Locations

7 sites across 6 countries: Burkina Faso, Côte d’Ivoire, Democratic Republic of the Congo, Madagascar, Mali, Senegal

Source: ClinicalTrials.gov record NCT04425434. Inclusion in this directory is not an endorsement.